Candel Therapeutics (CADL) Profit After Tax: 2020-2023
Historic Profit After Tax for Candel Therapeutics (CADL) over the last 4 years, with Dec 2023 value amounting to -$11.1 million.
- Candel Therapeutics' Profit After Tax fell 118.02% to -$11.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year decrease of 101.55%. This contributed to the annual value of -$55.2 million for FY2024, which is 45.50% down from last year.
- Latest data reveals that Candel Therapeutics reported Profit After Tax of -$11.1 million as of Q4 2023, which was down 31.54% from -$8.4 million recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Profit After Tax registered a high of $1.6 million during Q4 2021, and its lowest value of -$17.1 million during Q2 2021.
- For the 3-year period, Candel Therapeutics' Profit After Tax averaged around -$7.7 million, with its median value being -$8.6 million (2022).
- In the last 5 years, Candel Therapeutics' Profit After Tax surged by 115.23% in 2021 and then tumbled by 877.78% in 2023.
- Quarterly analysis of 4 years shows Candel Therapeutics' Profit After Tax stood at -$10.5 million in 2020, then spiked by 115.23% to $1.6 million in 2021, then crashed by 418.86% to -$5.1 million in 2022, then slumped by 118.02% to -$11.1 million in 2023.
- Its Profit After Tax stands at -$11.1 million for Q4 2023, versus -$8.4 million for Q3 2023 and -$9.6 million for Q2 2023.